| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 5.483 | 49.786 | 97.139 | 280.538 | 308.113 | 460.858 | 493.311 | 421.461 | 342.314 |
| Total Income - EUR | 0 | 5.483 | 49.918 | 97.139 | 280.538 | 308.113 | 463.301 | 496.626 | 422.334 | 343.941 |
| Total Expenses - EUR | 88 | 3.985 | 44.621 | 83.233 | 272.116 | 299.389 | 427.037 | 454.599 | 415.453 | 307.830 |
| Gross Profit/Loss - EUR | -88 | 1.498 | 5.297 | 13.906 | 8.422 | 8.724 | 36.264 | 42.027 | 6.881 | 36.111 |
| Net Profit/Loss - EUR | -88 | 1.334 | 3.804 | 12.735 | 5.616 | 5.898 | 32.470 | 37.119 | 2.686 | 30.334 |
| Employees | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Bioline Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 71 | 70 | 69 | 10.555 | 8.685 | 7.014 | 4.889 | 12.453 | 21.959 | 29.529 |
| Current Assets | 2 | 8.222 | 19.325 | 83.872 | 48.388 | 113.480 | 196.510 | 194.414 | 194.261 | 164.296 |
| Inventories | 0 | 2.936 | 15.378 | 20.856 | 34.980 | 98.677 | 188.540 | 172.761 | 162.817 | 109.499 |
| Receivables | 0 | 1.707 | 202 | 46.918 | 9.581 | 5.714 | 3.791 | 16.588 | 29.248 | 50.669 |
| Cash | 2 | 3.578 | 3.745 | 16.098 | 3.826 | 9.089 | 4.179 | 5.065 | 2.195 | 4.128 |
| Shareholders Funds | -1.218 | 173 | 3.973 | 16.636 | 21.930 | 27.412 | 59.274 | 96.577 | 98.970 | 30.848 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 1.291 | 8.120 | 15.421 | 77.791 | 35.143 | 93.082 | 142.125 | 110.290 | 117.250 | 162.977 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bioline Srl